Capricor Therapeutics (CAPR)

Capricor Therapeutics (CAPR) Stock Price & Analysis


CAPR Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$3.30 - $6.58
Previous Close$4.69
Average Volume (3M)65.77K
Market Cap
Enterprise Value$79.11M
Total Cash (Recent Filing)$45.17M
Total Debt (Recent Filing)$5.77M
Price to Earnings (P/E)-4.0
Aug 10, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.17
Shares Outstanding25,269,926
10 Day Avg. Volume63,397
30 Day Avg. Volume65,774
Standard Deviation0.68
Financial Highlights & Ratios
Price to Book (P/B)96.58
Price to Sales (P/S)39.68
Price to Cash Flow (P/CF)6.90
P/FCF Ratio6.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue14.29
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.76
Price Target Upside214.14% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Capricor Therapeutics’s price range in the past 12 months?
Capricor Therapeutics lowest stock price was $3.30 and its highest was $6.58 in the past 12 months.
    What is Capricor Therapeutics’s market cap?
    Currently, no data Available
    When is Capricor Therapeutics’s upcoming earnings report date?
    Capricor Therapeutics’s upcoming earnings report date is Aug 10, 2023 which is in 63 days.
      How were Capricor Therapeutics’s earnings last quarter?
      Capricor Therapeutics released its earnings results on May 11, 2023. The company reported -$0.31 earnings per share for the quarter, beating the consensus estimate of -$0.32 by $0.01.
        Is Capricor Therapeutics overvalued?
        According to Wall Street analysts Capricor Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Capricor Therapeutics pay dividends?
          Capricor Therapeutics does not currently pay dividends.
          What is Capricor Therapeutics’s EPS estimate?
          Capricor Therapeutics’s EPS estimate is -$0.35.
            How many shares outstanding does Capricor Therapeutics have?
            Capricor Therapeutics has 25,269,926 shares outstanding.
              What happened to Capricor Therapeutics’s price movement after its last earnings report?
              Capricor Therapeutics reported an EPS of -$0.31 in its last earnings report, beating expectations of -$0.32. Following the earnings report the stock price went down -1.946%.
                Which hedge fund is a major shareholder of Capricor Therapeutics?
                Among the largest hedge funds holding Capricor Therapeutics’s share is Oracle Investment Management Inc. It holds Capricor Therapeutics’s shares valued at N/A.


                  Capricor Therapeutics Stock Smart Score

                  The Capricor Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Capricor Therapeutics

                  Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA.


                  Top 5 ETFs holding CAPR

                  Market Value
                  Smart Score
                  iShares Core S&P Total U.S. Stock Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold CAPR. The ETFs are listed according to market value of CAPR within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Aethlon Medical
                  Onconova Therapeutics
                  vTv Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis